Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2797 to 2805 of 2805 entries
Sorted by: Best Match Show Resources per page
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler.

Pharmaceutics

Son YJ, Miller DP, Weers JG.
PMID: 34575603
Pharmaceutics. 2021 Sep 21;13(9). doi: 10.3390/pharmaceutics13091528.

This manuscript critically reviews the design and delivery of spray-dried particles for the achievement of high total lung doses (TLD) with a portable dry powder inhaler. We introduce a new metric termed the product density, which is simply the...

Cite
Son YJ, Miller DP, Weers JG. Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler. Pharmaceutics. 2021;13(9)doi: 10.3390/pharmaceutics13091528.
Son, Y. J., Miller, D. P., & Weers, J. G. (2021). Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler. Pharmaceutics, 13(9), . https://doi.org/10.3390/pharmaceutics13091528
Son, Yoen-Ju, et al. "Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler." Pharmaceutics vol. 13,9 (2021). doi: https://doi.org/10.3390/pharmaceutics13091528
Son YJ, Miller DP, Weers JG. Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler. Pharmaceutics. 2021 Sep 21;13(9). doi: 10.3390/pharmaceutics13091528. PMID: 34575603; PMCID: PMC8470347.
Copy Download .nbib Format: NLM
Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2).

EClinicalMedicine

Castro M, Kerwin E, Miller D, Pedinoff A, Sher L, Cardenas P, Knorr B, Lawrence D, Ossa D, Wang W, Maspero JF.
PMID: 33997741
EClinicalMedicine. 2021 Apr 25;35:100847. doi: 10.1016/j.eclinm.2021.100847. eCollection 2021 May.

BACKGROUND: These studies assessed the efficacy and safety of fevipiprant, an oral antagonist of the prostaglandin DMETHODS: ZEAL-1 (NCT03215758) and ZEAL-2 (NCT03226392) are two replicate, phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group studies in which fevipiprant 150 mg once...

Cite
Castro M, Kerwin E, Miller D, et al. Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2). EClinicalMedicine. 2021;35:100847doi: 10.1016/j.eclinm.2021.100847.
Castro, M., Kerwin, E., Miller, D., Pedinoff, A., Sher, L., Cardenas, P., Knorr, B., Lawrence, D., Ossa, D., Wang, W., & Maspero, J. F. (2021). Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2). EClinicalMedicine, 35100847. https://doi.org/10.1016/j.eclinm.2021.100847
Castro, Mario, et al. "Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2)." EClinicalMedicine vol. 35 (2021): 100847. doi: https://doi.org/10.1016/j.eclinm.2021.100847
Castro M, Kerwin E, Miller D, Pedinoff A, Sher L, Cardenas P, Knorr B, Lawrence D, Ossa D, Wang W, Maspero JF. Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2). EClinicalMedicine. 2021 Apr 25;35:100847. doi: 10.1016/j.eclinm.2021.100847. eCollection 2021 May. PMID: 33997741; PMCID: PMC8099656.
Copy Download .nbib Format: NLM
Cyclicality, Mortality, and the Value of Time: The Case of Coffee Price Fluctuations and Child Survival in Colombia.

The journal of political economy

Miller G, Urdinola BP.
PMID: 22090662
J Polit Econ. 2010 Feb;118(1):113-155. doi: 10.1086/651673.

Recent studies demonstrate procyclical mortality in wealthy countries, but there are reasons to expect a countercyclical relationship in developing nations. We investigate how child survival in Colombia responds to fluctuations in world Arabica coffee prices - and document starkly...

Cite
Miller G, Urdinola BP. Cyclicality, Mortality, and the Value of Time: The Case of Coffee Price Fluctuations and Child Survival in Colombia. J Polit Econ. 2010;118(1):113-155doi: 10.1086/651673.
Miller, G., & Urdinola, B. P. (2010). Cyclicality, Mortality, and the Value of Time: The Case of Coffee Price Fluctuations and Child Survival in Colombia. The journal of political economy, 118(1), 113-155. https://doi.org/10.1086/651673
Miller, Grant, and Urdinola, B Piedad. "Cyclicality, Mortality, and the Value of Time: The Case of Coffee Price Fluctuations and Child Survival in Colombia." The journal of political economy vol. 118,1 (2010): 113-155. doi: https://doi.org/10.1086/651673
Miller G, Urdinola BP. Cyclicality, Mortality, and the Value of Time: The Case of Coffee Price Fluctuations and Child Survival in Colombia. J Polit Econ. 2010 Feb;118(1):113-155. doi: 10.1086/651673. PMID: 22090662; PMCID: PMC3214991.
Copy Download .nbib Format: NLM
Black Resilience: A Strategic Asset for Engaging Heterosexual Black Canadian Men in Community Responses to HIV.

Journal of racial and ethnic health disparities

Antabe R, Miller D, Kohoun B, Okonufua O, Husbands W.
PMID: 33686622
J Racial Ethn Health Disparities. 2021 Mar 08; doi: 10.1007/s40615-021-01011-w. Epub 2021 Mar 08.

Black people's disproportionate burden of HIV in Canada has raised questions about whether they are sufficiently resilient to HIV, and how to promote resilience. In this paper, we critically examine the issue of resilience among heterosexual Black men in...

Cite
Antabe R, Miller D, Kohoun B, et al. Black Resilience: A Strategic Asset for Engaging Heterosexual Black Canadian Men in Community Responses to HIV. J Racial Ethn Health Disparities. 2021;doi: 10.1007/s40615-021-01011-w.
Antabe, R., Miller, D., Kohoun, B., Okonufua, O., & Husbands, W. (2021). Black Resilience: A Strategic Asset for Engaging Heterosexual Black Canadian Men in Community Responses to HIV. Journal of racial and ethnic health disparities, . https://doi.org/10.1007/s40615-021-01011-w
Antabe, Roger, et al. "Black Resilience: A Strategic Asset for Engaging Heterosexual Black Canadian Men in Community Responses to HIV." Journal of racial and ethnic health disparities vol. (2021). doi: https://doi.org/10.1007/s40615-021-01011-w
Antabe R, Miller D, Kohoun B, Okonufua O, Husbands W. Black Resilience: A Strategic Asset for Engaging Heterosexual Black Canadian Men in Community Responses to HIV. J Racial Ethn Health Disparities. 2021 Mar 08; doi: 10.1007/s40615-021-01011-w. Epub 2021 Mar 08. PMID: 33686622.
Copy Download .nbib Format: NLM
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

DeGrazia D, Miller FG.
PMID: 33786589
Clin Infect Dis. 2021 Dec 06;73(11):2121-2125. doi: 10.1093/cid/ciab278.

The coronavirus disease 2019 (COVID-19) pandemic has stimulated massive investment in biomedical research with the aims of understanding the disease and developing effective vaccine and therapeutic interventions. What role should animal research play in this scientific endeavor? Both the...

Cite
DeGrazia D, Miller FG. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective. Clin Infect Dis. 2021;73(11):2121-2125doi: 10.1093/cid/ciab278.
DeGrazia, D., & Miller, F. G. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(11), 2121-2125. https://doi.org/10.1093/cid/ciab278
DeGrazia, David, and Miller, Franklin G. "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,11 (2021): 2121-2125. doi: https://doi.org/10.1093/cid/ciab278
DeGrazia D, Miller FG. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective. Clin Infect Dis. 2021 Dec 06;73(11):2121-2125. doi: 10.1093/cid/ciab278. PMID: 33786589; PMCID: PMC8083670.
Copy Download .nbib Format: NLM
Targeting treatment options for castration-resistant prostate cancer.

American journal of clinical and experimental urology

Miller DR, Ingersoll MA, Teply BA, Lin MF.
PMID: 33816699
Am J Clin Exp Urol. 2021 Feb 15;9(1):101-120. eCollection 2021.

Prostate cancer (PCa) is the most commonly diagnosed solid tumor and the second leading cause of cancer-related deaths in U.S. men in 2020. Androgen-deprivation therapy (ADT) is the standard of care for metastatic PCa. Unfortunately, PCa relapse often occurs...

Cite
Miller DR, Ingersoll MA, Teply BA, et al. Targeting treatment options for castration-resistant prostate cancer. Am J Clin Exp Urol. 2021;9(1):101-120
Miller, D. R., Ingersoll, M. A., Teply, B. A., & Lin, M. F. (2021). Targeting treatment options for castration-resistant prostate cancer. American journal of clinical and experimental urology, 9(1), 101-120.
Miller, Dannah R, et al. "Targeting treatment options for castration-resistant prostate cancer." American journal of clinical and experimental urology vol. 9,1 (2021): 101-120.
Miller DR, Ingersoll MA, Teply BA, Lin MF. Targeting treatment options for castration-resistant prostate cancer. Am J Clin Exp Urol. 2021 Feb 15;9(1):101-120. eCollection 2021. PMID: 33816699; PMCID: PMC8012826.
Copy Download .nbib Format: NLM
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.

Contemporary clinical trials communications

Yamada M, Miller DM, Lowe M, Rowe C, Wood D, Soyer HP, Byrnes-Blake K, Parrish-Novak J, Ishak L, Olson JM, Brandt G, Griffin P, Spelman L, Prow TW.
PMID: 34401600
Contemp Clin Trials Commun. 2021 Aug 04;23:100830. doi: 10.1016/j.conctc.2021.100830. eCollection 2021 Sep.

BLZ-100 (tozuleristide) is an intraoperative fluorescent imaging agent that selectively detects malignant tissue and can be used in real time to guide tumor resection. The purpose of this study was to assess the safety, tolerability, and pharmacokinetics of BLZ-100...

Cite
Yamada M, Miller DM, Lowe M, et al. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemp Clin Trials Commun. 2021;23:100830doi: 10.1016/j.conctc.2021.100830.
Yamada, M., Miller, D. M., Lowe, M., Rowe, C., Wood, D., Soyer, H. P., Byrnes-Blake, K., Parrish-Novak, J., Ishak, L., Olson, J. M., Brandt, G., Griffin, P., Spelman, L., & Prow, T. W. (2021). A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemporary clinical trials communications, 23100830. https://doi.org/10.1016/j.conctc.2021.100830
Yamada, Miko, et al. "A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients." Contemporary clinical trials communications vol. 23 (2021): 100830. doi: https://doi.org/10.1016/j.conctc.2021.100830
Yamada M, Miller DM, Lowe M, Rowe C, Wood D, Soyer HP, Byrnes-Blake K, Parrish-Novak J, Ishak L, Olson JM, Brandt G, Griffin P, Spelman L, Prow TW. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemp Clin Trials Commun. 2021 Aug 04;23:100830. doi: 10.1016/j.conctc.2021.100830. eCollection 2021 Sep. PMID: 34401600; PMCID: PMC8355837.
Copy Download .nbib Format: NLM
The bachelor's to Ph.D. STEM pipeline no longer leaks more women than men: a 30-year analysis.

Miller DI, Wai J.
UIID-AD: 719
2015;6. doi: 10.3389/fpsyg.2015.00037.

For decades, research and public discourse about gender and science have often assumed that women are more likely than men to "leak" from the science pipeline at multiple points after entering college. We used retrospective longitudinal methods to investigate...

Cite
Miller DI, Wai J. The bachelor's to Ph.D. STEM pipeline no longer leaks more women than men: a 30-year analysis. 2015;6doi: 10.3389/fpsyg.2015.00037.
Miller, D. I., & Wai, J. (2015). The bachelor's to Ph.D. STEM pipeline no longer leaks more women than men: a 30-year analysis. 6. https://doi.org/10.3389/fpsyg.2015.00037
Miller, D I, and Wai, J. "The bachelor's to Ph.D. STEM pipeline no longer leaks more women than men: a 30-year analysis." vol. 6 (2015). doi: https://doi.org/10.3389/fpsyg.2015.00037
Miller DI, Wai J. The bachelor's to Ph.D. STEM pipeline no longer leaks more women than men: a 30-year analysis. 2015;6. doi: 10.3389/fpsyg.2015.00037. UIID-AD: 719.
Copy Download .nbib Format: NLM
Exploring and Enhancing Spatial Thinking: Links to Achievement in Science, Technology, Engineering, and Mathematics?.

Uttal DH, Miller DI, Newcombe NS.
UIID-AD: 310
2013;22:367-373. doi: 10.1177/0963721413484756.

Although neglected in traditional education, spatial thinking plays a critical role in achievement in science, technology, engineering, and mathematics (STEM) fields. We review this relationship and investigate the malleability of spatial thinking. Can spatial thinking be improved with training,...

Cite
Uttal DH, Miller DI, Newcombe NS. Exploring and Enhancing Spatial Thinking: Links to Achievement in Science, Technology, Engineering, and Mathematics?. 2013;22:367-373doi: 10.1177/0963721413484756.
Uttal, D. H., Miller, D. I., & Newcombe, N. S. (2013). Exploring and Enhancing Spatial Thinking: Links to Achievement in Science, Technology, Engineering, and Mathematics?. 22367-373. https://doi.org/10.1177/0963721413484756
Uttal, D H, et al. "Exploring and Enhancing Spatial Thinking: Links to Achievement in Science, Technology, Engineering, and Mathematics?." vol. 22 (2013): 367-373. doi: https://doi.org/10.1177/0963721413484756
Uttal DH, Miller DI, Newcombe NS. Exploring and Enhancing Spatial Thinking: Links to Achievement in Science, Technology, Engineering, and Mathematics?. 2013;22:367-373. doi: 10.1177/0963721413484756. UIID-AD: 310.
Copy Download .nbib Format: NLM
Showing 2797 to 2805 of 2805 entries